HC Wainwright Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $15.00
Lexeo Therapeutics (NASDAQ:LXEO – Free Report) had its price objective lowered by HC Wainwright from $23.00 to $15.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Lexeo Therapeutics’ Q1 2026 earnings at ($0.62) EPS, Q2 2026 earnings at ($0.63) EPS, […]
Lexeo Therapeutics (NASDAQ:LXEO – Free Report) had its price objective lowered by HC Wainwright from $23.00 to $15.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Lexeo Therapeutics’ Q1 2026 earnings at ($0.62) EPS, Q2 2026 earnings at ($0.63) EPS, […]
